POSSIS RECEIVES FDA CLEARANCE FOR GUARDDOG OCCLUSION SYSTEM

Possis Medical, Inc., announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its GuardDOG Occlusion System for use during the treatment of peripheral vascular disease. The GuardDOG System enables physicians to quickly and effectively manage local blood flow while employing interventional techniques and devices to treat vascular disease.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=4975941)